Hinge Health, Inc. (HNGE) Form 8-K — Nov 2, 2026
$HNGEForm 8-KItems 2.02, 5.02, 7.01, 9.01Filed Nov 2, 2026, 4:06 PM ET0001628280-26-068872Original filing
Hinge Health reported record Q3 2026 results with revenue up 52% year-over-year to $235.0 million and GAAP net income of $57.4 million ($0.66 diluted EPS), a sharp swing from a year-ago loss. Free cash flow reached $112.7 million, a 48% margin. The company raised full-year 2026 guidance, with revenue of $879-881 million (50% YoY growth at the midpoint) and non-GAAP operating margin raised to a 30% midpoint. LTM calculated billings rose 54% to $960.3 million and clients grew 28% to 3,270.
Key figures
- Eps
- 0.66
- Revenue
- 235000000
- Guidance
- Q4 2026 revenue $249-251M (46% YoY growth at midpoint); FY2026 revenue raised to $879-881M (50% YoY growth at midpoint); FY2026 non-GAAP income from operations raised to $266-268M (30% non-GAAP operating margin at midpoint)
- Net Income
- 57398000
- Revenue Yoy
- 52%
- Cash Position
- 358500000
- Clients
- 3270
- Fcf margin
- 48%
- Clients yoy
- 28%
- Free cash flow
- 112658000
- Ltm billings yoy
- 54%
- Non g AAP eps diluted
- 0.71
- Gaap operating margin
- 21%
- Ltm calculated billings
- 960300000
- Non g AAP income from operations
- 77209000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.